GMT Capital’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.46M Buy
+2,704,364
New +$7.48M 0.26% 39

Other funds holding AVXL

GMT Capital's AVXL Position: Q3 2026 in Review

GMT Capital opened a new position in Anavex Life Sciences (AVXL) in Q3 2026: 2,704,364 shares worth $5.46M. The stake represents 0.26% of the portfolio and ranks #39 among its holdings.

132 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.

  • GMT Capital held 2,704,364 shares of Anavex Life Sciences worth $5.46M as of Q3 2026.
  • Anavex Life Sciences was a new GMT Capital position in Q3 2026.
  • Anavex Life Sciences made up 0.26% of GMT Capital's portfolio in Q3 2026, its #39 holding.
  • 132 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.

Based on GMT Capital's 13F filing for Q3 2026, filed 16 Nov 2026.